First published in Diabetes, Obesity and Metabolism on 2013 Jul.Diabetes Obes Metab. 2013 Jul;15(7):642-9. doi: 10.1111/dom.12076. Epub 2013 Feb 25....
Read Article
First published in Diabetic Medicine on 2016 Mar.Diabet Med. 2016 Mar;33(3):391-4. doi: 10.1111/dme.12833. Authors: Grunberger G, Forst T, Fernández Landó...
Read Article
First published in Journal Expert Opinion on Pharmacotherapy on 2016 Aug.Expert Opin Pharmacother. 2016 Aug;17(12):1703-8. doi: 10.1080/14656566.2016.1206079. Authors: Forst T...
Read Article
This open-label, nonrandomized, single-dose, phase 1 study evaluated the pharmacokinetics and safety of murepavadin, a novel peptide antibiotic for the treatment of serious Pseudomonas aeruginosa infections.
Dulaglutide and liraglutide, both glucagon-like peptide-1 (GLP-1) receptor agonists, improve glycaemic control and reduce weight in patients with type 2 diabetes. I